Elevated transglutaminase-induced bonds in PHF tau in Alzheimer's disease

Brain Research

Volumn 851, Issue 1-2, 1999, Pages 154-163

  Norlund, Maryam A ^a   Lee, John M ^a   Zainelli, Gina M ^a   Muma, Nancy A ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cross linking; Neurofibrillary tangle; Paired helical filament; Polymerization; Transglutaminase

Indexed keywords

PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; TAU PROTEIN;

ALZHEIMER DISEASE; ARTICLE; CALCIUM HOMEOSTASIS; CROSS LINKING; HUMAN; HUMAN TISSUE; IMMUNOAFFINITY CHROMATOGRAPHY; IMMUNOBLOTTING; NEUROFIBRILLARY TANGLE; PAIRED HELICAL FILAMENT; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN POLYMERIZATION; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN; DIPEPTIDES; HUMANS; MIDDLE AGED; TAU PROTEINS; TRANSGLUTAMINASES;

EID: 0033373675     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)02179-4     Document Type: Article

References (52)

1. McKee A.C., Kosik K.S., Kowall N.W. Neuritic pathology and dementia in Alzheimer's disease. Ann. Neurol. 30:1991;156-165.
2. Suenaga T., Hirano A., Llena J.F., Ksiezak-Reding H., Yen S.-H., Dickinson D.W. Modified Bielschowsky and immunocytochemical studies on cerebellar plaques in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 49:1991;31-40.
3. Trojanowski J.Q., Lee V.M. Phosphorylation of paired helical filament tau in Alzheimer's disease neurofibrillary lesions - focusing on phosphatases. FASEB J. 9:1995;1570-1576.
4. Wang J.Z., Grundke-Iqbal I., Iqbal K. Glycosylation of microtubule-associated protein tau: an abnormal posttranslational modification in Alzheimer's disease. Nat. Med. 2:1992;871-875.
5. Yan S.D., Yan S.F., Chen X., Fu J., Chen M., Kuppusamy P., Smith M.A., Perry G., Godman G.C., Nawroth P., Zweier J.L., Stern D. Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid b-peptide. Nat. Med. 1:1995;693-698.
6. Guttmann R.P., Erickson A.C., Johnson G.V.W. t Self-association: stabilization with a chemical cross-linker and modulation by phosphorylation and oxidation state. J. Neurochem. 64:1995;1209-1215.
7. Schweers O., Mandelkow E.M., Biernat J., Mandelkow E. Oxidation of cysteine-322 in the repeat domain of microtubule-associated protein tau controls the in vitro assembly of paired helical filaments. Proc. Natl. Acad. Sci. U. S. A. 92:1995;8463-8467.
8. Goedert M., Jakes R., Spillantini M.G., Hasegawa M., Smith M.J., Crowther R.A. Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulfated glycosaminoglycans. Nature. 383:1996;550-553.
9. Kampers T., Friedhoff P., Biernat J., Mandelkow E.M., Mandelkow E. RNA stimulates aggregation of microtubule-associated tau into Alzheimer-like paired helical filaments. FEBS Lett. 399:1996;344-349.
10. Wilson D.M., Binder L.I. Polymerization of microtubule-associated protein tau under near-physiological conditions. J. Biol. Chem. 270:1995;24306-24314.
11. Wilson D.M., Binder L.I. Free fatty acids stimulate the polymerization of tau and amyloid beta peptides. In vitro evidence for a common effector of pathogenesis in Alzheimer's disease. Am. J. Pathol. 150:1997;2181-2195.
12. Selkoe D.J., Ihara Y., Salazar F.J. Alzheimer's disease: insolubility of partially purified paired helical filaments in sodium dodecyl sulfate and urea. Science. 215:1982;1243-1245.
13. Porta R., Esposito R., Gentile V., Mariniello L., Peluso G., Metafora S. Transglutaminase-catalyzed modifications of SV-IV, a major protein secreted from the rat seminal vesicle epithelium. Int. J. Pept. Protein Res. 35:1990;117-122.
14. Dudek S.M., Johnson G.V. Transglutaminase catalyzes the formation of sodium dodecyl sulfate-insoluble, Alz-50-reactive polymers of tau. J. Neurochem. 61:1993;1159-1162.
15. Mercken M., Grynspan F., Nixon R.A. Differential sensitivity to proteolysis by brain calpain of adult human tau, fetal human tau, and PHF-tau. FEBS Lett. 368:1995;10-14.
16. Dudek S.M., Johnson G.V. Transglutaminase facilitates the formation of polymers of the beta-amyloid peptide. Brain Res. 651:1994;129-133.
17. Appelt D.M., Kopen G.C., Boyne L.J., Balin B.J. Localization of transglutaminase in hippocampal neurons: implications for Alzheimer's disease. J. Histochem. Cytochem. 44:1996;1421-1427.
18. Johnson G.V.W., Cox T.M., Lockhart J.P., Zinnerman M.D., Miller M.L., Powers R.E. Transglutaminase activity is increase in Alzheimer's disease brain. Brain Res. 751:1997;323-329.
19. Hyman B.T., Trojanowski J.Q. Editorial on consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J. Neuropathol. Exp. Neurol. 56:1997;1095-1097.
20. Liu W.K., Reding H.K., Yen S.H. Abnormal tau proteins from Alzheimer's disease brains. J. Biol. Chem. 266:1991;21723-21727.
21. Greenberg S.G., Davies P. A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. Proc. Natl. Acad. Sci. U. S. A. 87:1990;5827-5831.
22. Laemmli U.K. Cleavage of structural proteins during head assembly of bacteriophage T4. Nature. 227:1970;680-685.
23. e(glutamyl)lysine isopeptide levels during cell growth: an enzymic and immunological study. Int. J. Cancer. 48:1991;221-226.
24. Lustigman S., Brotman B., Huima T., Castelhano A.L., Singh R.N., Mehta K., Prince A.M. Tranglutaminase-catalyzed reaction is important for molting of Onchocerca volvulus third-stage larvae. Antimicrob. Agents Chemother. 39:1995;1913-1919.
25. Otvos L., Feiner L., Lang E., Szendrei G.I., Goedert M., Lee V.M.Y. Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404. Neurosci. Res. 39:1994;669-673.
26. Biernat J., Mandelkow E.-M., Schroter C., Lichtenberg-Kraag B., Steiner B., Berling B., Meyer H.E., Mercken M., Vandermeeren A., Goedert M., Mandelkow E. The switch of tau protein to an Alzheimer-like state includes the phosphorylation of two serine-proline motifs upstream of the microtubule binding region. EMBO J. 11:1992;1593-1597.
27. Goedert M., Jakes R., Vanmechelen E. Monoclonal antibody AT8 recognizes tau protein phosphorylated at both serine 202 and threonine 205. Neurosci. Lett. 189:1995;167-170.
28. LoPresti P., Szuchet S., Papasozomenos S.C., Zinkowski R.P., Binder L.I. Functional implications for the microtubule-associated protein tau: localization in oligodendrocyptes. Proc. Natl. Acad. Sci. U. S. A. 92:1995;10369-10373.
29. Papasozomenos S.C., Su Y. Rapid dephosphorylation of tau in heat-shocked fetal rat cerebral explants: prevention and hyperphosphorylation by inhibitors of protein phosphatase PP1 and PP2A. J. Neurochem. 65:1995;396-406.
30. Cork L.C., Sternberger N.H., Sternberger L.A., Casanova M.F., Struble R.G., Price D.L. Phosphorylated neurofilament antigens in neurofibrillary tangles in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 45:1986;56-64.
31. Goedert M., Jakes R. Expression of separate isoforms of human tau protein: correlation with the tau pattern in brain and effects on tubulin polymerization. EMBO J. 9:1990;4225-4230.
32. Singer S.M., Muma N.A. Tau in aluminum-induced neurofibrillary tangles. Neurotoxicology. 18:1997;63-76.
33. Ksiezak-Reding H., Davies P., Yen S.-H. Alz 50, a monoclonal antibody to Alzheimer's disease antigen, cross-reacts with t proteins from bovine and normal human brain. J. Biol. Chem. 263:1988;7943-7947.
34. Lowry O. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
35. Rasool C.G., Abraham C., Anderton B.H., Haugh M., Kahn J., Selkoe D.J. Alzheimer's disease: immunoreactivity of neurofibrillary tangles with anti-neurofilament and anti-paired helical filament antibodies. Brain Res. 310:1984;249-260.
36. Vickers J.C., Riederer B.M., Marugg R.A., Bueescherrer V., Buee L., Delacourte A., Morrison J.H. Alterations in neurofilament protein immunoreactivity in human hippocampal neurons related to normal aging and Alzheimer's disease. Neuroscience. 62:1994;1-13.
37. Gentile V., Thomazy V., Piacentini M., Fesus L., Davies P.J. Expression of tissue transglutaminase in Balb-C 3T3 fibroblasts: effects on cellular morphology and adhesion. J. Cell Biol. 119:1992;463-474.
38. Selkoe D.J., Abraham C., Ihara Y. Brain transglutaminase: in vitro crosslinking of human neurofilament proteins into insoluble polymers. Proc. Natl. Acad. Sci. U. S. A. 79:1982;6070-6074.
39. Hand D., Perry M.J.M., Haynes L.W. Cellular transglutaminases in neural development. Int. J. Dev. Neurosci. 11:1993;709-720.
40. Furuya Y., Lundmo P., Short A.D., Gill D.L., Issacs J.T. The role of calcium, pH, and cell proliferation in the programmed (apoptotic) death of androgen-independent prostatic cancer cells induced by thapsigargin. Cancer Res. 54:1994;6167-6175.
41. Ikeda J., Nagashima G., Saito N., Nowak T.S. Jr., Joo F., Mies G., Lohs J.M., Ruetzler C.A., Klatzo I. Putative neuroexcitation in cerebral ischemia and brain injury. Stroke. 21:1990;11165-11170.
42. Landfield P.W. Hippocampal neurobiological mechanisms of age-related memory dysfunction. Neurobiol. Aging. 9:1988;571-579.
43. Mattson M.P., Lovell M.A., Ehmann W.D., Markesbery W.R. Comparison of the effects of elevated intracellular aluminum and calcium levels on neuronal survival and tau immunoreactivity. Brain Res. 602:1993;21-31.
44. Dewar D., Graham D.I., Teasdale G.M., McCulloch J. Cerebral ischemia induces alterations in tau and ubiquitin proteins. Dementia. 5:1994;168-173.
45. Mattson M.P. Degenerative and protective signaling mechanisms in the neurofibrillary pathology of AD. Neurobiol. Aging. 16:1995;447-457.
46. McKee A.C., Kosik K.S., Kennedy M.B., Kowall N.W. Hippocampal neurons predisposed to neurofibrillary tangle formation are enriched in type II calcium/calmodulin-dependent protein kinase. J. Neuropathol. Exp. Neurol. 49:1990;49-63.
47. Querfurth H.W., Selkoe D.J. Calcium ionophore increases amyloid beta peptide production by cultured cells. Biochemistry. 33:1994;4550-4561.
48. Stanwell C., Burke T.R. Jr., Yuspa S.H. The erbstatin analogue methyl 2,5-dihydroxycinnamate cross-links proteins and is cytotoxic to normal and neoplastic epithelial cells by a mechanism independent of tyrosine kinase inhibition. Cancer Res. 55:1995;4950-4956.
49. Guo Q., Furukawa K., Sopher B.L., Pham D.G., Xie J., Robinson N., Martin G.M., Mattson M.P. Alzheimer's PS-1 mutation perturbs calcuim homeostasis and sensitizes PC12 cells to death induced by amyloid b-peptide. NeuroReport. 8:1996;379-383.
50. Groenen P.J., Seccia M., Smulders R.H., Gravela E., Cheeseman K.H., de Jong W.W. Exposure of beta H-crystallin to hydroxyl radicals enhances the transglutaminase-susceptibility of its existing amine-donor and amine-acceptor sites. Biochem J. 295:1993;399-404.
51. Igarashi S., Koide R., Shimohata T., Yamada M., Hayashi Y., Takano H., Date H., Oyake M., Sato T., Sato A., Egawa S., Ikeuchi T., Tanaka H., Nakano R., Tanaka K., Hozumi I., Inuzuka T., Takahashi H., Tsuji S. Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch. Nat. Genet. 18:1998;111-117.
52. M.V. Karpuj, H. Garren, H. Slunt, D.L. Price, J. Gusella, M.W. Becher, L. Steinman, Transglutaminase aggregates huntingtin into nonamyloidogenic polymers, and its enzymatic activity increases in Huntington's disease brain nuclei, Proc. Natl. Acad. Sci. U. S. A. (1999) 7388-7393.